CAV1 can promote cancer progression via inhibiting ferroptosis in head and neck squamous cell carcinoma (Lu et al., 2022) and drives the execution of acute immune-mediated hepatic damage (Deng et al., 2020). The gene discussed is CAV1; the disease is head and neck squamous cell carcinoma.